Nova Health Labs Welcomes New Advisory Board Members to Drive Patient-Centered Innovation

ATLANTA - Rezul -- Nova Health Labs, an emerging technology startup in AI-driven digital healthcare solutions, is proud to announce the appointment of two distinguished experts to its Advisory Board: Jess Quiring and Anisa Palmer. Their invaluable expertise in patient advocacy, cancer care, and healthcare navigation will ensure Nova Health Labs remains deeply aligned with the needs of both providers and patients.

Jess Quiring, BS, CN-BA, OPN-CG, is an oncology patient navigator and the owner of Patient Navigation Advisors. With over a decade of experience in cancer patient and family care, Jess is dedicated to making cancer diagnosis, treatment, and support services more accessible through a health equity lens.

Anisa Palmer is the CEO of I Will Survive, Inc., a nonprofit dedicated to supporting breast cancer survivors. With over 17 years of leadership experience and a personal connection to the cause, Anisa has championed patient advocacy and resource access for underserved communities.

More on Rezul News

• $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
• West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
• Walnut Hills Launches Off-Grid Hempcrete Homes and Eco-Retreat in Western NC
• The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
• Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild

"We are honored to welcome Jess and Anisa to our Advisory Board," said Trellis Usher, CEO of Nova Health Labs. "Their deep understanding of the patient experience, clinical workflows, and healthcare navigation will be instrumental in shaping our technology to better serve providers and patients alike."

Nova Health Labs is committed to leveraging AI to enhance patient engagement, streamline communication, and improve outcomes for cancer care centers, clinics, and healthcare providers. "As the use of AI continues to evolve, it's important that we maintain an appropriate balance between artificial and human intelligence because healthcare at its core should be and remain uniquely human-centered", according to Usher.

The addition of these two powerhouse advocates strengthens the company's mission to bridge the gap between healthcare technology and patient-centered care.

For more information: https://www.novahealthlabs.com